Stay updated on Regeneron Press Releases
Sign up to get notified when there's something new on the Regeneron Press Releases page.

Latest updates to the Regeneron Press Releases page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now includes the approval of Dupixent® as the first biologic medicine for COPD in Japan, while the previous announcement regarding EYLEA HD®'s positive Phase 3 results has been removed.SummaryDifference17%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has been updated to include information about the Regeneron Science Talent Search 2025 Awards, which offers over $1.8 million to high school seniors for innovative scientific research. The previous financial report regarding Regeneron's fourth quarter and full year 2024 results has been removed.SummaryDifference23%
- Check39 days agoChange DetectedThe page has added information about a late-breaking presentation of pivotal data for Dupixent® in relation to Bullous Pemphigoid, while it has removed details about a competition for high school scientists with significant awards.SummaryDifference14%
- Check53 days agoChange DetectedThe web page has added pagination controls, allowing users to navigate between multiple pages of content more easily.SummaryDifference3%
- Check61 days agoChange DetectedThe webpage has added significant announcements regarding Regeneron's investor conference presentations and the acceptance of Linvoseltamab's BLA for FDA review, which are crucial updates in the context of pharmaceutical developments.SummaryDifference11%
- Check68 days agoChange DetectedThe webpage has added significant updates regarding EYLEA HD® (aflibercept) Injection, including positive Phase 3 results and three-year outcomes for patients, while numerous sections related to stock information and corporate governance have been removed.SummaryDifference61%
Stay in the know with updates to Regeneron Press Releases
Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.